New safety information for montelukast

被引：0

作者：

机构：

来源：

Reactions Weekly | 1998年 / 731卷 / 1期

关键词：

Asthma; Corticosteroid; Adverse Reaction; Healthcare Professional; Medium Release;

D O I：

10.2165/00128415-199807310-00007

中图分类号：

学科分类号：

摘要：

引用

页码：3 / 3

共 50 条

[31] Safety, Efficacy, and Patient Acceptability of Montelukast in Exercise-Induced Asthma
Kansra, S.
Mazzei, A.
Bhatt, J.
CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2012, 4 : 231 - 239
[32] Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients
Scichilone, Nicola
Battaglia, Salvatore
Benfante, Alida
Bellia, Vincenzo
CLINICAL INTERVENTIONS IN AGING, 2013, 8 : 1329 - 1337
[33] VTE risk included in the new safety information about Evra
Reactions Weekly, 2006, 1130 (1) : 2 - 2
[34] New safety information regarding the use of doripenem for injection [Doribax]
Reactions Weekly, 2012, 1388 (1) : 3 - 3
[35] Information Credibility Evaluation in Presence of Users' Safety in New Retailing
Wang, Dong
Wang, Kehong
Yan, Lemei
Yue, Zeyu
Zhang, Jiewen
JOURNAL OF WEB ENGINEERING, 2021, 20 (03): : 641 - 667
[36] New safety information emerges from postmarketing use of ritonavir
不详
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (02) : 126 - 126
[37] Trileptal label updated in the US to reflect new safety information
Reactions Weekly, 2005, 1048 (1) : 2 - 2
[38] Inconsistent procedures for handling new drug safety information in the Netherlands
Reactions Weekly, 2022, 1901 (1) : 9 - 9
[39] New and Practical Synthesis of Montelukast Sodium, an Antiasthmatic Drug
Saravanan, M.
Satyanarayana, B.
Reddy, P. Pratap
SYNTHETIC COMMUNICATIONS, 2013, 43 (15) : 2050 - 2056
[40] Information and information safety right
Rabovskij, S.V.
Elektrosvyaz, 2001, (02): : 33 - 34

← 1 2 3 4 5 →